Cite
HARVARD Citation
Rekdal, Ö. et al. (n.d.). Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors. Journal for immunotherapy of cancer. p. . [Online].